نتایج جستجو برای: iron chelation

تعداد نتایج: 145419  

Journal: :Haematologica 2014
Francesca Rossi Silverio Perrotta Giulia Bellini Livio Luongo Chiara Tortora Dario Siniscalco Matteo Francese Marco Torella Bruno Nobili Vincenzo Di Marzo Sabatino Maione

The pathogenesis of bone resorption in β-thalassemia major is multifactorial and our understanding of the underlying molecular and cellular mechanisms remains incomplete. Considering the emerging importance of the endocannabinoid/endovanilloid system in bone metabolism, it may be instructive to examine a potential role for this system in the development of osteoporosis in patients with β-thalas...

Journal: :Journal of biological regulators and homeostatic agents 2012
E Prus E Fibach

Iron-overload is a major clinical problem in various diseases. Under this condition, serum iron which surpasses the binding capacity of transferrin is present as non-transferrin bound iron and cellular unbound Labile Iron Pool (LIP) is increased. LIP participates in the generation of free radicals, including reactive oxygen species (ROS). Increased ROS, with concomitant decrease in anti-oxidant...

Journal: :The Biochemical journal 2008
Lakshmi D Devanur Robert W Evans Patricia J Evans Robert C Hider

Current iron chelation therapy consists primarily of DFO (desferrioxamine), which has to be administered via intravenous infusion, together with deferiprone and deferasirox, which are orally-active chelators. These chelators, although effective at decreasing the iron load, are associated with a number of side effects. Grady suggested that the combined administration of a smaller bidentate chela...

Journal: :Hematology. American Society of Hematology. Education Program 2008
Mario Cazzola Matteo G Della Porta Luca Malcovati

Most patients with myelodysplastic syndrome eventually become dependent on regular red cell transfusions. This dependency has a negative impact on clinical outcome, primarily because it may be associated with more severe marrow failure. In addition, however, transfusion dependency may involve clinical consequences of chronic anemia and iron overload. Although transfusion iron is primarily taken...

Journal: :iranian journal of medical sciences 0
peyman eshghi

although successful iron chelation with deferiprone is associated with significant complications, patient’s compliance with medication regimens is of a high priority. the present study did evaluate the complications and compliance of domestically-manufactured deferiprone combined with desferrioxamine for iron chelation therapy. a total of 32 major beta thalassemic patients with cardiomyopathy w...

Journal: :Journal of Cardiovascular Magnetic Resonance 2008
Mark A Tanner Renzo Galanello Carlo Dessi Gillian C Smith Mark A Westwood Annalisa Agus Martina Pibiri Sunil V Nair J Malcolm Walker Dudley J Pennell

BACKGROUND In thalassemia major (TM), severe cardiac siderosis can be treated by continuous parenteral deferoxamine, but poor compliance, complications and deaths occur. Combined chelation therapy with deferiprone and deferoxamine is effective for moderate myocardial siderosis, but has not been prospectively examined in severe myocardial siderosis. METHODS T2* cardiovascular magnetic resonanc...

2015
Paul J Schmidt Tim Racie Mark Westerman Kevin Fitzgerald James S Butler Mark D Fleming

β-thalassemias result from diminished β-globin synthesis and are associated with ineffective erythropoiesis and secondary iron overload caused by inappropriately low levels of the iron regulatory hormone hepcidin. The serine protease TMPRSS6 attenuates hepcidin production in response to iron stores. Hepcidin induction reduces iron overload and mitigates anemia in murine models of β-thalassemia ...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید